搜索临床试验以:白细胞介素-1受体拮抗剂
总计11605个结果
-
Karolinska University HospitalKarolinska Institutet招聘中
-
Assistance Publique Hopitaux De Marseille未知
-
Indiana UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完全的
-
University Hospital, Basel, Switzerland完全的
-
Assistance Publique - Hôpitaux de ParisSwedish Orphan Biovitrum招聘中
-
King Faisal Specialist Hospital & Research CenterSociety of Critical Care Medicine未知
-
Margaret RagniWyeth is now a wholly owned subsidiary of Pfizer; University of North Carolina终止
-
Massachusetts General Hospital完全的
-
University of Missouri-ColumbiaAmerican Society for Metabolic and Bariatric Surgery招聘中
-
James J. IrrgangBrooke Army Medical Center; Wake Forest University终止
-
University of British ColumbiaHeart and Stroke Foundation of Canada完全的
-
Forteza, Albert, M.D.Ministry of Health, Spain未知
-
University of Erlangen-Nürnberg Medical SchoolMerck Sharp & Dohme LLC撤销
-
Medical University of ViennaRoche Pharma AG完全的
-
Bayer主动,不招人2 型糖尿病 | 慢性肾病日本, 西班牙, 荷兰, 丹麦, 美国
-
Karolinska InstitutetBristol-Myers Squibb; Sanofi; Swedish Heart Lung Foundation完全的
-
Brigham and Women's HospitalBoston Children's Hospital完全的
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI); FDA Office of Orphan Products Development; National...完全的
-
Ajou University School of MedicineBoryung Pharmaceutical Co., Ltd未知缺血性中风 | 血压
-
National Heart, Lung, and Blood Institute (NHLBI)完全的心肌梗塞 | 高血压 | 动脉粥样硬化 | 心力衰竭,充血美国
-
National Heart, Lung, and Blood Institute (NHLBI)完全的心肌梗塞 | 高血压 | 动脉粥样硬化 | 心力衰竭,充血美国
-
Astellas Pharma Global Development, Inc.完全的胃食管连接部 CLDN18.2 阳性腺癌 | CLDN18.2阳性食管腺癌 | CLDN18.2阳性胃腺癌德国, 拉脱维亚
-
University Hospital, Rouen完全的
-
Bassett HealthcareGoshen Health System; Reid Health终止